1
|
Saeed H, Martini ND, Scahill S. Exploring telepharmacy: A bibliometric analysis of past research and future directions. Res Social Adm Pharm 2024; 20:805-819. [PMID: 38714397 DOI: 10.1016/j.sapharm.2024.04.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 03/30/2024] [Accepted: 04/29/2024] [Indexed: 05/09/2024]
Abstract
This bibliometric review analyzes the evolution of telepharmacy research, significantly amplified by the COVID-19 pandemic. By employing bibliometric analysis, the study aims to provide a comprehensive overview of the current state and emerging trends in telepharmacy. This approach helps in identifying key areas of growth, predominant themes, and potential gaps in the literature. Utilizing data from 330 papers (1981-2023) sourced from Scopus and analyzed with Bibliometrix™, this study applies both performance analysis and science mapping methods to examine the telepharmacy literature. The findings reveal a consistent growth in telepharmacy research, with an 8.07 % average annual growth rate. Performance analysis highlights key authors, influential works, and leading journals and countries in the field. Document co-citation analysis identifies four developmental phases of telepharmacy: emergence, take-off, expansion, and future trajectory by uncovering the intellectual structure of the field. Co-words analysis elucidates evolving conceptual structures and significant subfields over time. These findings serve to inform practitioners and researchers about the evolving landscape of telepharmacy, guiding future research and practice in this increasingly important field.
Collapse
Affiliation(s)
- Hina Saeed
- School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
| | - Nataly Dominica Martini
- School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Shane Scahill
- School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| |
Collapse
|
2
|
Hussain A, Bowen AM. Exploring Pharmacist Roles in Telepharmacy for Chronic Disease Management in New York State: A Qualitative Inquiry into Improving Implementation, Patient Communication, and Healthcare Technology Support. Cureus 2024; 16:e62982. [PMID: 39044868 PMCID: PMC11265808 DOI: 10.7759/cureus.62982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2024] [Indexed: 07/25/2024] Open
Abstract
Background This qualitative study aimed to collect information regarding pharmacists' roles in telepharmacy and chronic disease management (CDM). The literature review was conducted on historical overview, CDM overview, social determinants of health (SDOH), disparities, hospital readmissions, adverse drug events, best practices, and global implications of telepharmacy. Materials and methods Eleven licensed pharmacists from New York working in retail or hospital settings were interviewed using 16 questions. The interview covered topics such as CDM, hospital readmissions, adverse drug events, best practices, SDOH, and health disparities. The recordings of these interviews were transcribed and coded for each open-ended question, resulting in 136 different codes. Results According to the comprehensive review of interview transcripts, there is still an urgent need for communication between healthcare providers and patients, pharmacist training for telepharmacy services and SDOH, and healthcare technology support. CDM can be advanced by pharmacists by understanding patient barriers, SDOHs, health disparities, and pill burdens, as well as incorporating a multidisciplinary approach to patient care. Pharmacists must facilitate open communication, overcome technological barriers, seek support from stakeholders for telepharmacy training, and integrate new mobile applications to improve telepharmacy implementation and operations for providing interventions. Conclusion The research provides insights into the comprehensive impact of telepharmacy on healthcare delivery and its potential to transform CDM. With the expansion of telepharmacy, individuals living with chronic diseases can experience improved medication adherence and overall health outcomes.
Collapse
Affiliation(s)
- Azhar Hussain
- Pharmaceutical and Biomedical Sciences, Touro University College of Pharmacy, New York, USA
| | - Alyncia M Bowen
- Healthcare Administration, Franklin University, Columbus, USA
| |
Collapse
|
3
|
Yap M, Edwards G, Gibbs H, Newnham H, Hancock N, Tong EY. A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic. Int J Clin Pharm 2024; 46:522-528. [PMID: 38368283 DOI: 10.1007/s11096-024-01701-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 01/02/2024] [Indexed: 02/19/2024]
Abstract
BACKGROUND The COVID-19 pandemic created systemic challenges in patient care delivery. AIM To evaluate the impact on pharmacist activities during pharmacist participation in ward rounds via telehealth, compared to physical attendance. METHOD A single-centre, retrospective cohort study conducted from 18th Aug through 26th Oct 2020. Patients admitted to COVID and non-COVID general medical teams were included. Pharmacists attended ward rounds via telehealth for COVID teams; physical attendance continued for non-COVID teams. Telehealth involved pharmacists interacting with clinicians and patients virtually via videoconferencing whilst stationed remotely on the ward. Routine clinical pharmacy activities during telehealth ward rounds were compared to those during face-to-face ward rounds using comparative statistics. RESULTS Among the 1230 patients included (762 COVID, 468 non-COVID), pharmacist participation in telehealth ward rounds demonstrated significantly more documented activities compared with face-to-face rounds (mean 6.7 vs 4.9 per patient per day, p < 0.001). The telehealth cohort exhibited a higher number of orders placed via pharmacy-partnered medication charting (3.0 vs 2.4 per patient per day, p < 0.001), medication orders verified (2.3 vs 1.1, p < 0.001), and documented pharmacy notes (0.6 vs 0.2, p < 0.001). No significant difference was observed in medication requests processed (0.4 vs 0.4, p = 738), whilst non-COVID patients had more discharge prescription items generated (0.3 vs 0.7, p < 0.001). CONCLUSION Pharmacist involvement in medical ward rounds via telehealth enabled the ongoing provision of advanced clinical pharmacy services to inpatients in isolation rooms during the COVID-19 pandemic. This approach resulted in a greater number of pharmacy activities during telehealth ward rounds compared to standard in-person attendance.
Collapse
Affiliation(s)
- Meng Yap
- Pharmacy Department, Alfred Health, Melbourne, VIC, Australia.
| | - Gail Edwards
- Pharmacy Department, Alfred Health, Melbourne, VIC, Australia
| | - Harry Gibbs
- General Medicine Unit, Alfred Health, Melbourne, VIC, Australia
| | - Harvey Newnham
- General Medicine Unit, Alfred Health, Melbourne, VIC, Australia
| | - Nicole Hancock
- General Medicine Unit, Alfred Health, Melbourne, VIC, Australia
| | - Erica Y Tong
- Pharmacy Department, Alfred Health, Melbourne, VIC, Australia
| |
Collapse
|
4
|
Bazzari FH, Bazzari AH. Utilizing ChatGPT in Telepharmacy. Cureus 2024; 16:e52365. [PMID: 38230387 PMCID: PMC10790595 DOI: 10.7759/cureus.52365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/15/2024] [Indexed: 01/18/2024] Open
Abstract
BACKGROUND ChatGPT is an artificial intelligence-powered chatbot that has demonstrated capabilities in numerous fields, including medical and healthcare sciences. This study evaluates the potential for ChatGPT application in telepharmacy, the delivering of pharmaceutical care via means of telecommunications, through assessing its interactions, adherence to instructions, and ability to role-play as a pharmacist while handling a series of life-like scenario questions. METHODS Two versions (ChatGPT 3.5 and 4.0, OpenAI) were assessed using two independent trials each. ChatGPT was instructed to act as a pharmacist and answer patient inquiries, followed by a set of 20 assessment questions. Then, ChatGPT was instructed to stop its act, provide feedback and list its sources for drug information. The responses to the assessment questions were evaluated in terms of accuracy, precision and clarity using a 4-point Likert-like scale. RESULTS ChatGPT demonstrated the ability to follow detailed instructions, role-play as a pharmacist, and appropriately handle all questions. ChatGPT was able to understand case details, recognize generic and brand drug names, identify drug side effects, interactions, prescription requirements and precautions, and provide proper point-by-point instructions regarding administration, dosing, storage and disposal. The overall means of pooled scores were 3.425 (0.712) and 3.7 (0.61) for ChatGPT 3.5 and 4.0, respectively. The rank distribution of scores was not significantly different (P>0.05). None of the answers could be considered directly harmful or labeled as entirely or mostly incorrect, and most point deductions were due to other factors such as indecisiveness, adding immaterial information, missing certain considerations, or partial unclarity. The answers were similar in length across trials and appropriately concise. ChatGPT 4.0 showed superior performance, higher consistency, better character adherence and the ability to report various reliable information sources. However, it only allowed an input of 40 questions every three hours and provided inaccurate feedback regarding the number of assessed patients, compared to 3.5 which allowed unlimited input but was unable to provide feedback. CONCLUSIONS Integrating ChatGPT in telepharmacy holds promising potential; however, a number of drawbacks are to be overcome in order to function effectively.
Collapse
Affiliation(s)
| | - Amjad H Bazzari
- Basic Scientific Sciences, Applied Science Private University, Amman, JOR
| |
Collapse
|
5
|
Abstract
INTRODUCTION Telepharmacy has the potential to enhance pharmacy services in oncology care, especially in remote areas. This scoping review explored the range, critical benefits and barriers of using telepharmacy services in oncology care. METHODS The scoping review followed the Arksey and O'Malley's five-stage framework to identify available evidence. PubMed, CINAHL, Embase, PsycINFO, Ovid MEDLINE and Scopus databases were searched for original research published between 2010 and 2020. The five dimensions of the Alberta Quality Matrix for Health were used to analyse reported outcomes. RESULTS Eligible articles (n = 21) were analysed. Telepharmacy in oncology care was used for follow-up, monitoring and counselling, intravenous chemotherapy and sterile compounding, expanding availability of pharmacy services, and remote education. Telepharmacy obtained high acceptability among cancer patients (n = 5) and healthcare professionals (n = 5), and increased accessibility of pharmaceutical services to underserved cancer populations (n = 2). Commonly cited effectiveness and safety outcomes were improved patient adherence (n = 5), increased pharmacy services (n = 3) and early identification of medication-related problems (n = 5). Telepharmacy improved efficiency in staffing and workload (n = 3), and increased cost savings (n = 3). A shortage of resources (n = 5), technical problems (n = 4) and prolonged turnaround time (n = 4), safety concerns (n = 2) and patient willingness to pay (n = 1) were identified barriers to implementing telepharmacy in oncology care. DISCUSSION Despite evidence pointing to the advantages and opportunities for expanding oncology pharmacy services through telepharmacy, certain challenges remain. Further research is needed to investigate safety concerns and patient willingness to pay for telepharmacy services.
Collapse
Affiliation(s)
- Anh Thu Vo
- Faculty of Medicine, Memorial University of Newfoundland, Canada
| | | |
Collapse
|
6
|
Griffeth JK, Shroff B, Carrico C, Cook P, Lindauer SJ. Patient perspectives on teledentistry and face-to-face doctor interaction during orthodontic treatment. Am J Orthod Dentofacial Orthop 2023; 163:328-337. [PMID: 36411229 DOI: 10.1016/j.ajodo.2021.11.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2021] [Revised: 11/01/2021] [Accepted: 11/01/2021] [Indexed: 11/20/2022]
Abstract
INTRODUCTION Teledentistry in orthodontics is growing, yet patient preferences for its use is unknown. This study aimed to determine the perceived value of doctor-to-patient face-to-face interaction, convenience, and attitudes toward specific uses of teledentistry among orthodontic patients. METHODS Private practice orthodontists emailed an electronic survey to active patients. Patients aged ≥18 years completed the survey regarding their treatment. Parents of patients aged <18 years completed a separate survey regarding their child's treatment. Responses were compared on the basis of patient characteristics (adult vs child, braces vs clear aligners, etc). RESULTS Three hundred and seventy-seven respondents from 8 orthodontic practices participated in the survey. Eighty-five percent of parents considered face-to-face interaction important, and 85% said that their child's treatment fit conveniently into their schedule. Adult responses were 86% and 89%, respectively. Adult preference for face-to-face was significantly higher than parents of adolescent patients (83% vs 78%; P = 0.038). Adults treated with clear aligners were less likely to strongly agree that their treatment fitted conveniently in their schedule (51% vs 76% in braces; P = 0.0490) and were more likely to be interested in using teledentistry (27% vs 18% in braces; P = 0.0429). CONCLUSIONS Most orthodontic patients prefer to be seen face-to-face. This is due to the high value placed on face-to-face interaction with the orthodontist. Most patients do not consider their treatment inconvenient. Patients prefer that teledentistry be used to enhance communication as opposed to replacing face-to-face interaction. Implementing teledentistry in orthodontics should be applied on a patient-to-patient basis with continued emphasis on the doctor-patient relationship.
Collapse
Affiliation(s)
- Jackson K Griffeth
- Department of Orthodontics, School of Dentistry, Virginia Commonwealth University, Richmond, Va
| | - Bhavna Shroff
- Department of Orthodontics, School of Dentistry, Virginia Commonwealth University, Richmond, Va.
| | - Caroline Carrico
- Department of Oral Health Promotion and Community Outreach, School of Dentistry, Virginia Commonwealth University, Richmond, Va
| | - Payton Cook
- School of Dentistry, Virginia Commonwealth University, Richmond, Va
| | - Steven J Lindauer
- Department of Orthodontics, School of Dentistry, Virginia Commonwealth University, Richmond, Va
| |
Collapse
|
7
|
Sugita H, Sato MT, Hasegawa T, Noma H, Ota E, Toyoda S. Clinical effectiveness of telepharmacy services in patients with non-communicable diseases in ambulatory care settings. Hippokratia 2023. [DOI: 10.1002/14651858.cd015136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Affiliation(s)
- Hideki Sugita
- Department of Hospital Pharmaceutics, School of Pharmacy; Showa University; Tokyo Japan
| | - Miki Takenaka Sato
- Department of Clinical Pharmacy; School of Pharmacy, Showa University; Tokyo Japan
| | - Takeshi Hasegawa
- Showa University Research Administration Center (SURAC); Showa University; Tokyo Japan
| | - Hisashi Noma
- Department of Data Science; The Institute of Statistical Mathematics; Tokyo Japan
| | - Erika Ota
- Global Health Nursing, Graduate School of Nursing Science; St Luke's International University; Chuo-ku Japan
| | - Shunsuke Toyoda
- Department of Inpatient Pharmacy; PIH Hospital-Whittier; Whittier California USA
| |
Collapse
|
8
|
Telepharmacy services to support patients with epilepsy in Thailand: A descriptive study. Heliyon 2023; 9:e13361. [PMID: 36816228 PMCID: PMC9932735 DOI: 10.1016/j.heliyon.2023.e13361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 12/13/2022] [Accepted: 01/29/2023] [Indexed: 02/04/2023] Open
Abstract
Background Telepharmacy shows an effective option to provide pharmacy services in several settings. It could improve patients' outcomes and save costs. However, the impact of a telepharmacy services in low resource settings remains limited. Objectives This study assessed the feasibility and effect of telepharmacy services on patient-reported clinical and economic outcomes among patients with epilepsy in Thailand. Methods A prospective descriptive study was conducted at a university hospital. Patients with epilepsy visiting the clinic from February 2021-December 2021 were included. Telepharmacy services were provided by hospital pharmacists through an application platform. Patients met a pharmacist synchronously using a video conference feature embedded in our developed website. Patients were interviewed for improved clinical symptoms, drug-related problems (DRPs), and health and social behaviors. Travel costs, food and accommodation costs and productivity costs due to hospital visits were also evaluated. Results A total of 80 patients were included. Of those, 39 patients (48.75%) were men, averaging 35.44 ± 15.09 years old. A total of 22 patients (27.50%) reported better clinical symptoms after the telepharmacy service. Sixty-four DRPs (69.56%) were observed, along with 28 health and social behavior problems (30.44%). The most common DRPs were adverse drug reactions (20/64; 69.56%), followed by patients' non-adherence (20/64; 31.25%). Sixty-six problems (68.04%) were corrected during the telepharmacy service. From the patient's perspective, the average direct nonmedical cost per visit was 1257 ± 857 THB/visit. Travel costs were the major cost driver, accounting for 67.7% of the total cost. Cost savings averaged 6511 ± 4996 THB/year or 54.75% of usual care. Conclusion Telepharmacy services are likely to improve patient outcomes, detect DRPs, and effectively provide cost-savings. However, further studies hosting a larger number of participants are warranted to assess the impacts of telepharmacy services.
Collapse
|
9
|
Shokri F, Bahrainian S, Tajik F, Rezvani E, Shariati A, nourigheimasi S, Shahrebabaki ES, Ebrahimi M, Shamoon F, Heidary M. The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID-19: A narrative review. Health Sci Rep 2023; 6:e1024. [PMID: 36620507 PMCID: PMC9811063 DOI: 10.1002/hsr2.1024] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Revised: 12/14/2022] [Accepted: 12/14/2022] [Indexed: 01/05/2023] Open
Abstract
Background and Aims Due of its low cost, rapid speed, data record, and vast communication coverage, information and communication technology might be useful for health-related fields in times of crisis. By providing medical or hygienic services to a patient who lives elsewhere using communication methods like email, fax, cellphones, applications, and wireless gadgets, telemedicine can aid in the better management of diseases. Reviewing the potential role of telemedicine in the pandemic of infectious diseases with a focus on the Coronavirus disease 2019 (COVID-19) epidemic was the main goal of this study. Methods "Google Scholar," "PubMed," "Science Direct," and "Scopus" databases were searched to collect the papers that identify the advantages and disadvantages of telemedicine in the disease pandemic. Searched keywords include: telepharmacy, telemedicine, remote communication, pandemic(s), epidemic, distant care, distant communication, phone consulation, video conference communication and patient education. Results Information and communication technology are crucial, especially when dealing with pandemics of infectious diseases like COVID-19. Less "in-person" patient visits to hospitals as a result of telemedicine eventually means less labor for the medical staff, less viral exposure for patients, and ultimately less disease spread. By establishing a bidirectional reciprocal relationship between patients and healthcare providers although they are in separate geographical areas, it can improve patient health status. Conclusion Governments are currently facing a significant budgetary burden because to the COVID-19 pandemic. Since patients are not sent to medical facilities in person, which could be a source of infection, telemedicine reduces disease spread while saving money.
Collapse
Affiliation(s)
- Fazlollah Shokri
- Department of Medical GeneticsFaculty of Medicine, Shahid Beheshti University of Medical SciencesTehranIran
| | - Sara Bahrainian
- Department of Food and Drug ControlSchool of Pharmacy, Ahvaz Jundishapur University of Medical SciencesAhvazIran
| | - Fatemeh Tajik
- Faculty of Medicine, Iran University of Medical SciencesTehranIran
| | - Elaheh Rezvani
- Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical SciencesIslamic Azad UniversityTehranIran
| | - Aref Shariati
- Molecular and medicine research center, Khomein University of Medical SciencesKhomeinIran
| | | | - Elahe Saberi Shahrebabaki
- Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung DiseasesShahid Beheshti University of Medical SciencesTehranIran
| | - Maryam Ebrahimi
- Faculty of Pharmacy, Tehran University of Medical SciencesTehranIran
| | - Farhan Shamoon
- Student Research Committee, Sabzevar University of Medical SciencesSabzevarIran
| | - Mohsen Heidary
- Cellular and Molecular Research Center, Sabzevar University of Medical SciencesSabzevarIran
| |
Collapse
|
10
|
Begnoche BR, David Butler C, Carson PH, Darr A, Jenkins MT, Le T, McDaniel RB, Mourad H, Shipman CJ, Stratton TP, Tran K, Wong KK. ASHP Statement on Telehealth Pharmacy Practice. Am J Health Syst Pharm 2022; 79:1728-1735. [PMID: 35866463 DOI: 10.1093/ajhp/zxac188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | | | | | | | | | - Trinh Le
- UNC Health Care, Raleigh, NC, USA
| | | | | | | | | | | | - Kong Kit Wong
- VA Capitol Health Care Network (VISN 5), Washington, DC, USA
| |
Collapse
|
11
|
Matsumoto Y, Kizaki H, Ikeda Y, Nakamura S, Kina S, Nagai T, Nasu T, Miyamoto K, Hori S. Telepharmacy in mountainous depopulated areas of Japan: an exploratory interview study of patients' perspectives. Drug Discov Ther 2022; 15:337-340. [PMID: 34980762 DOI: 10.5582/ddt.2021.01102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Japan has an ageing population and geographical impediments to healthcare access, so an experimental trial of telepharmacy has recently been implemented in remote islands or remote areas of Japan prior to the formal implementation. This exploratory study was conducted to understand patients' perspectives on telepharmacy in a mountainous depopulated area away from urban areas of Japan. Semi-structured interviews were conducted with four elderly patients, who were all of the patients receiving telepharmacy in Toyone village, Japan, at the time of the survey. The transcribed interview data were qualitatively analyzed by coding and categorization. The subjects thought telepharmacy would be advantageous to overcome poor access to a clinic and to improve convenience in processes ranging from medical examination to obtaining prescribed medicines. However, they pointed out the low digital literacy of the elderly. Also, they had low expectations for pharmacists, because they had previously had no relationship with pharmacists due to lack of pharmacies in the area. To promote telepharmacy, efforts to eliminate resistance to smartphones and to provide support for smartphone operations are needed among the elderly. Work is also needed to establish how pharmacists should best be involved in patient care and health support in remote areas. Our findings suggest that telepharmacy is useful in remote areas of Japan, but in locations where there is no existing relationship with pharmacists, it would be desirable for pharmacists to be actively involved with the community to maximize its effectiveness.
Collapse
Affiliation(s)
- Yusaku Matsumoto
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - Hayato Kizaki
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - Yuki Ikeda
- Kyowa Chemical Co., Ltd., Nagoya, Aichi, Japan
| | | | | | | | | | | | - Satoko Hori
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan
| |
Collapse
|
12
|
Narayan SW, Abraham I, Erstad BL, Haas CE, Sanders A, Patanwala AE. Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping review. Am J Health Syst Pharm 2021; 78:1576-1590. [PMID: 34003209 DOI: 10.1093/ajhp/zxab214] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
PURPOSE Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists' interventions in acute care settings. METHODS An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. RESULTS The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. CONCLUSION Cost-avoidance studies of pharmacists' interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications.
Collapse
Affiliation(s)
- Sujita W Narayan
- School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Australia
| | - Ivo Abraham
- College of Pharmacy, University of Arizona, Tucson, AZ, USA
| | - Brian L Erstad
- College of Pharmacy, University of Arizona, Tucson, AZ, USA
| | - Curtis E Haas
- University of Rochester Medical Center, Rochester, NY, USA
| | - Arthur Sanders
- College of Medicine, University of Arizona, Tucson, AZ, USA
| | - Asad E Patanwala
- School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Australia, and Royal Prince Alfred Hospital, Sydney, Australia
| |
Collapse
|
13
|
Al Mazrouei N, Ibrahim RM, Al Meslamani AZ, Abdel-Qader DH, Mohamed Ibrahim O. Virtual pharmacist interventions on abuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions. J Am Pharm Assoc (2003) 2021; 61:331-339. [PMID: 33676838 PMCID: PMC7879024 DOI: 10.1016/j.japh.2021.02.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 01/24/2021] [Accepted: 02/07/2021] [Indexed: 11/24/2022]
Abstract
OBJECTIVES This study aimed to investigate the frequency, nature, and clinical significance of pharmacist interventions on over-the-counter (OTC) medicines with abuse potential across community pharmacies with and without virtual care. METHODS In this prospective observational study, a trained research team observed the dispensary teams of 12 community pharmacies in the United Arab Emirates (UAE), 6 of which were operating virtual pharmacy care. A standardized data collection form was used to include information about dispensing of OTC medicines and pharmacist interventions on those with abuse/misuse potential. The clinical significance of the interventions was evaluated by a multidisciplinary committee. RESULTS The frequency of pharmacist interventions on OTC medicines with abuse potential across pharmacies with and without virtual services was 83.2% versus 91.0%, respectively, whereas the frequency of pharmacist interventions on OTC medicines with misuse potential across pharmacies with and without virtual services was 79.8% versus 41.2%, respectively. The proportions of clinically significant interventions across pharmacies with and without virtual services were 19.7% versus 10.5%, respectively. Cough medicines were dispensed significantly more across pharmacies with virtual care than across pharmacies without virtual care (25.6% vs. 9.7%, respectively; P = 0.04). Asking the patient to seek the advice of an addiction specialist (adjusted odds ratio = 4.11; P = 0.001) versus refusing to sell the drug was more likely to be associated with pharmacies with virtual services than with pharmacies operating traditional pharmacy services. CONCLUSION Virtual pharmaceutical care is a potential approach to reduce the abuse/misuse of OTC medicines but needs some improvements regarding detection of these cases. The UAE is the first country in the region to implement and regulate virtual pharmacy practice.
Collapse
|
14
|
Ibrahim OM, Ibrahim RM, Z Al Meslamani A, Al Mazrouei N. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J Telemed Telecare 2020; 29:18-27. [PMID: 33059541 DOI: 10.1177/1357633x20964347] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Remote pharmacist interventions have achieved much more attention during the coronavirus disease 2019 (COVID-19) outbreak, since they reduce the risk of transmission and can potentially increase the access of vulnerable populations, such as patients with COVID-19, to pharmaceutical care. This study aimed to examine differences in rates and types of pharmacist interventions related to COVID-19 and medication dispensing errors (MDEs) across community pharmacies with and without telepharmacy services. METHODS This was a prospective, disguised, observational study conducted over four months (from March 2020 to July 2020) in 52 community pharmacies (26 with and 26 without telepharmacy) across all seven states of the United Arab Emirates using proportionate random sampling. A standardised data-collection form was developed to include information about patient status, pharmacist interventions and MDEs. RESULTS The test (telepharmacy) group pharmacies provided pharmaceutical care to 19,974 patients, of whom 6371 (31.90%) and 1213 (6.07%) were probable and confirmed cases of COVID-19, respectively. The control group pharmacies provided care to 9151 patients, of whom 1074 (11.74%) and 33 (0.36%) were probable and confirmed cases of COVID-19, respectively. Rates of MDEs and their subcategories, prescription-related errors and pharmacist counselling errors across pharmacies with telepharmacy versus those without remote services were 15.81% versus 19.43% (p < 0.05), 5.38% versus 10.08% (p < 0.05) and 10.42% versus 9.35% (p > 0.05), respectively. DISCUSSION This is one of the first studies to provide high-quality evidence of the impact of telepharmacy on COVID-19 patients' access to pharmaceutical care and on medication dispensing safety.
Collapse
Affiliation(s)
- Osama M Ibrahim
- Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, United Arab Emirates.,Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Egypt
| | - Rana M Ibrahim
- Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, United Arab Emirates
| | - Ahmad Z Al Meslamani
- College of Pharmacy, Al Ain University of Science and Technology, United Arab Emirates
| | - Nadia Al Mazrouei
- Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, United Arab Emirates
| |
Collapse
|
15
|
Badowski ME, Wright EA, Bainbridge J, Michienzi SM, Nichols SD, Turner KM, Wicke C, Awad J, Thompkins A, Martin RD. Implementation and evaluation of comprehensive medication management in telehealth practices. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2020. [DOI: 10.1002/jac5.1210] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Affiliation(s)
| | | | | | | | | | | | | | - John Awad
- American College of Clinical Pharmacy; Lenexa Kansas
| | | | | |
Collapse
|
16
|
Goode JV, Owen J, Page A, Gatewood S. Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States. PHARMACY 2019; 7:E106. [PMID: 31382690 PMCID: PMC6789634 DOI: 10.3390/pharmacy7030106] [Citation(s) in RCA: 82] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2019] [Revised: 07/29/2019] [Accepted: 07/31/2019] [Indexed: 11/25/2022] Open
Abstract
Community-based pharmacy practice is evolving from a focus on product preparation and dispensing to becoming a health care destination within the four walls of the traditional community-based pharmacy. Furthermore, community-based pharmacy practice is expanding beyond the four walls of the traditional community-based pharmacy to provide care to patients where they need it. Pharmacists involved in this transition are community-based pharmacist practitioners who are primarily involved in leading and advancing team-based patient care services in communities to improve the patient health. This paper will review community-based pharmacy practice innovations and the role of the community-based pharmacist practitioner in the United States.
Collapse
Affiliation(s)
- Jean-Venable Goode
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA 23298, USA.
| | - James Owen
- Practice and Science Affairs, American Pharmacists Association, Washington, DC 20037, USA
| | - Alexis Page
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA 23298, USA
| | - Sharon Gatewood
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA 23298, USA
| |
Collapse
|
17
|
Expansion of Telemedicine Services: Telepharmacy, Telestroke, Teledialysis, Tele-Emergency Medicine. Crit Care Clin 2019; 35:519-533. [PMID: 31076051 DOI: 10.1016/j.ccc.2019.02.007] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
As more specialized care gets centralized in centers of excellence, patients admitted to rural hospitals may be at a disadvantage at the time of accessing expertise or receiving advanced care. In this setting, telemedicine models provide a justification to equalize care across different levels. The diversity in telemedicine services is vast and is expanding. Even with all the subsets of telemedicine, including telepharmacy, telestroke, teledialysis, and tele-emergency medicine, the reasons for providing services and associated limitations are similar. However, there is a lack of empirical research including best practices and resultant outcomes for these subsets of telemedicine models.
Collapse
|
18
|
Taylor AM, Bingham J, Schussel K, Axon DR, Dickman DJ, Boesen K, Martin R, Warholak TL. Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program. J Manag Care Spec Pharm 2018; 24:813-818. [PMID: 30058982 PMCID: PMC10397863 DOI: 10.18553/jmcp.2018.24.8.813] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Pharmacist-delivered medication therapy management (MTM) services can improve patient outcomes, yet little is known about outpatient, interprofessional telepharmacy programs. OBJECTIVE To evaluate an outpatient, interprofessional telehealth chronic care management (CCM) pilot program. METHODS This 6-month program integrated family medicine providers, a university-based medication management telepharmacist, and an interprofessional care coordinator using telehealth solutions for CCM and pharmacy education services. A physician referred patients at risk for medicine-related problems to the telepharmacist. Eligible patients had 3 or more chronic conditions or took at least 5 medications, were aged 18 years and older, and had at least 1 appointment with their primary care provider during the program. The care coordinator met patients in person to facilitate these virtual clinic processes. The telepharmacist conducted a comprehensive medication review (CMR) via video-conferencing technology, providing CCM based on primary diagnosis, current medications and allergies, laboratory results, and previous chart notes. The consultation was documented in the electronic health record (EHR) for provider review and modification in real time. RESULTS 69 patients received telepharmacy consultations and on-site registered nurse support during the program. Most patients were female (56.5%), aged 51-70 years (60.1%), Caucasian (72.4%), and non-Hispanic/Latino (71.0%). Patients had 1-9 chronic conditions, such as hypertension (82.6%), diabetes (56.5%), hyperlipidemia (31.9%), depression (30.4%), and osteoporosis (29.0%). Most patients (94.2%) took at least 5 chronic disease medications, such as statins (11.2%), nonsteroidal anti-inflammatory drugs (8.4%), selective serotonin reuptake inhibitors (6.5%), beta blockers (6.5%), and calcium channel blockers (5.6%). The telepharmacist completed 200 interventions for safety (49.0%), vaccines (24.5%), care gaps per national consensus guidelines (13.5%), adherence (10.0%), and cost savings (3.0%). Patients' providers accepted one third (n = 75, 37.5%) of the telepharmacist recommendations (e.g., monitoring and medication changes). CONCLUSIONS This telehealth program constituted an added service for patients while simultaneously filling a gap in on-site pharmacist counseling services. Integrating the telepharmacist and registered nurse was crucial to clinical service provision. The results are encouraging; however, more research must examine the effectiveness of telehealth services in reaching underserved populations, improving patient care, and decreasing health care costs. DISCLOSURES External funding from SinfonîaRx was used to help conduct this project. Boesen is employed by SinfonîaRx. At the time this project was conducted, Martin was employed at the University of Arizona Medication Management Center but is now employed by SinfonîaRx. The other authors have no disclosures to report. This original research was presented as a poster at the Academy of Managed Care Pharmacy Nexus 2015; October 26-29, 2015; in Orlando, FL.
Collapse
Affiliation(s)
- Ann M Taylor
- 1 University of Arizona College of Pharmacy, Tucson
| | | | | | | | | | | | - Rose Martin
- 2 University of Arizona Medication Management Center, Tucson
| | | |
Collapse
|
19
|
Margusino-Framiñán L, Cid-Silva P, Castro-Iglesias Á, Mena-de-Cea Á, Rodríguez-Osorio I, Pernas-Souto B, Vázquez-Rodríguez P, López-Calvo S, Martín-Herranz I. Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis. Telemed J E Health 2018; 25:399-406. [PMID: 30036159 DOI: 10.1089/tmj.2018.0041] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Background/Introduction: Pharmacist teleconsultations, combined with home drug delivery or mail-order pharmacy (MOP), can help hospital outpatients with difficulties accessing treatment. The objectives of this study are to describe a teleconsultation protocol and to evaluate clinical, economic, and patient-perceived quality results. Materials and Methods: A cohort observational study was carried out for 3 years on HIV outpatients. Clinical variables were adherence, plasma HIV-RNA, and CD4+ levels. A pharmacoeconomic analysis was carried out through a cost-minimization study. Patient-perceived quality was assessed through a satisfaction survey. Simple random sampling was performed for 95% safety, accuracy ±1%, and losses ±20%. Results: The 38 participants (sample size) consisted of 82% male patients, aged 44.7 ± 8.4 years. There were 854 teleconsultations and 100% treatment adherence. All HIV outpatients kept virally suppressed (p = 1.00) and maintained a controlled immunological level (p = 0.87). The economic evaluation revealed 137 ± 23 € patient/year costs-saved and 18.5 ± 7.2 h/patient/year working time gained. Patient-perceived quality average score was >9.4 out of 10 in all items; the most valued factors were the saving of direct costs and reconciliation with work commitments (45%) and the least valued attributes were making the payment for the shipment and having to adjust to a telephone appointment (41%). Discussion/Conclusions: A teleconsultation protocol associated with home antiretrovirals delivery or MOP obtains a high degree of satisfaction from the HIV hospital outpatients receiving treatment, without repercussions on the therapeutic objectives and with the saving of important direct costs for the patient and indirect costs in relation to labor productivity.
Collapse
Affiliation(s)
- Luis Margusino-Framiñán
- 1 Pharmacy Service, A Coruña University Hospital, A Coruña, Spain.,2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain
| | - Purificación Cid-Silva
- 1 Pharmacy Service, A Coruña University Hospital, A Coruña, Spain.,2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain
| | - Ángeles Castro-Iglesias
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | - Álvaro Mena-de-Cea
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | - Iria Rodríguez-Osorio
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | - Berta Pernas-Souto
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | - Pilar Vázquez-Rodríguez
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | - Soledad López-Calvo
- 2 Division of Clinical Virology, A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, SERGAS, A Coruña University (UDC), A Coruña, Spain.,3 Infectious Diseases Unit, Internal Medicine Service, A Coruña University Hospital, A Coruña, Spain
| | | |
Collapse
|
20
|
Strnad K, Shoulders BR, Smithburger PL, Kane-Gill SL. A Systematic Review of ICU and Non-ICU Clinical Pharmacy Services Using Telepharmacy. Ann Pharmacother 2018; 52:1250-1258. [DOI: 10.1177/1060028018787213] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Objective: To assess the impact of telepharmacy services in the acute care setting. Data Sources: EMBase, MEDLINE, and SCOPUS database searches were performed through April 2018. Study Selection and Data Extraction: PRISMA guidelines were applied for this systematic review. All English-language studies meeting the criteria of the following population, intervention, comparison, and outcome question were included: What impact does the provision of inpatient clinical pharmacy services delivered via telemedicine have on patient outcomes compared with standard of care? Data Synthesis: A total of 11 studies were identified for the acute care setting, including 3 for critically ill patients. All studies demonstrated a positive impact on patient outcomes, nursing satisfaction, and disease management. Varying modes of telepharmacy technology were used, such as remote access to electronic medical records, faxing or scanning documents, pictures or webcams. For communication purposes, telepharmacists used email or electronic communication, facsimile, video review, or telephone to speak directly with hospital personnel and patients. Relevance to Patient Care and Clinical Practice: Inpatient telepharmacy is feasible and should be leveraged to further enhance patient care by complementing existing service models. Conclusions: Telepharmacy services enhanced patient outcomes, improved nursing satisfaction, and expanded services within inpatient settings. Similar technologies were leveraged in non–intensive care units (ICUs) and ICUs, but the goals of telepharmacy appeared to differ. ICUs focused on an expansion of services in the ICU and non-ICUs addressed improved patient outreach in rural areas.
Collapse
Affiliation(s)
- Kyle Strnad
- UPMC Presbyterian Shadyside, Pittsburgh, PA, USA
| | | | | | | |
Collapse
|
21
|
Alexander E, Butler CD, Darr A, Jenkins MT, Long RD, Shipman CJ, Stratton TP. ASHP Statement on Telepharmacy. Am J Health Syst Pharm 2017; 74:e236-e241. [DOI: 10.2146/ajhp170039] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
| | | | | | | | | | - Colleen J. Shipman
- Department of Pharmacy, Oregon Health and Science University, Portland, OR
| | - Timothy P. Stratton
- Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota College of Pharmacy, Duluth, MN
| |
Collapse
|
22
|
Poudel A, Nissen LM. Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges. INTEGRATED PHARMACY RESEARCH AND PRACTICE 2016; 5:75-82. [PMID: 29354542 PMCID: PMC5741040 DOI: 10.2147/iprp.s101685] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The use of information and telecommunication technologies has expanded at a rapid rate, which has a strong influence on healthcare delivery in many countries. Rural residents and communities, however, often lack easy access to healthcare services due to geographical and demographical factors. Telepharmacy, a more recent concept that refers to pharmaceutical service provision, enables healthcare services, such as medication review, patients counseling, and prescription verification, by a qualified pharmacist for the patients located at a distance from a remotely located hospital, pharmacy, or healthcare center. Telepharmacy has many recognizable benefits such as the easy access to healthcare services in remote and rural locations, economic benefits, patient satisfaction as a result of medication access and information in rural areas, effective patient counseling, and minimal scarcity of local pharmacist and pharmacy services. Telepharmacy undoubtedly is a great concept, but it is sometimes challenging to put into practice. Inherent to the adoption of these practices are legal challenges and pitfalls that need to be addressed. The start-up of telepharmacy (hardware, software, connectivity, and operational cost) involves considerable time, effort, and money. For rural hospitals with fewer patients, the issue of costs appears to be one of the biggest barriers to telepharmacy services. Moreover, execution and implementation of comprehensive and uniform telepharmacy law is still a challenge. A well-developed system, however, can change the practice of pharmacy that is beneficial to both the rural communities and the hospitals or retail pharmacies that deliver these services.
Collapse
Affiliation(s)
- Arjun Poudel
- School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
| | - Lisa M Nissen
- School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
| |
Collapse
|
23
|
Keeys C, Kalejaiye B, Skinner M, Eimen M, Neufer J, Sidbury G, Buster N, Vincent J. Pharmacist-managed inpatient discharge medication reconciliation: A combined onsite and telepharmacy model. Am J Health Syst Pharm 2014; 71:2159-66. [DOI: 10.2146/ajhp130650] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
- Christopher Keeys
- Sibley Memorial Hospital–Johns Hopkins Medicine, Washington, DC, and Chief Executive Officer, MedNovations, Inc., Laurel, MD
| | | | | | | | | | - Gisele Sidbury
- Patient Care Services, Sibley Memorial Hospital–Johns Hopkins Medicine
| | - Norman Buster
- Patient Care Services, Sibley Memorial Hospital–Johns Hopkins Medicine
| | - Joan Vincent
- Patient Care Services, Sibley Memorial Hospital–Johns Hopkins Medicine
| |
Collapse
|
24
|
Sankaranarayanan J, Murante LJ, Moffett LM. A retrospective evaluation of remote pharmacist interventions in a telepharmacy service model using a conceptual framework. Telemed J E Health 2014; 20:893-901. [PMID: 24611489 PMCID: PMC4188381 DOI: 10.1089/tmj.2013.0362] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2013] [Revised: 01/10/2014] [Accepted: 01/10/2014] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES This retrospective cross-sectional study evaluated a telepharmacy service model using a conceptual framework to compare documented remote pharmacist interventions by year, hospital, and remote pharmacist and across rural hospitals with or without an on-site rural hospital pharmacist. MATERIALS AND METHODS Documented remote pharmacist interventions for patients at eight rural hospitals in the Midwestern United States during prospective prescription order review/entry from 2008 to 2011 were extracted from RxFusion(®) database (a home-grown system, i.e., internally developed program at The Nebraska Medical Center (TNMC) for capturing remote pharmacist-documented intervention data). The study authors conceptualized an analytical framework, mapping the 37 classes of remote pharmacist interventions to three broader-level definitions: (a) intervention, eight categories (interaction/potential interaction, contraindication, adverse effects, anticoagulation monitoring, drug product selection, drug regimen, summary, and recommendation), (b) patient medication management, two categories (therapy review and action), and (c) health system-centered medication use process, four categories (prescribing, transcribing and documenting, administering, and monitoring). Frequencies of intervention levels were compared by year, hospital, remote pharmacist, and hospital pharmacy status (with a remote pharmacist and on-site pharmacist or with a remote pharmacist only) using chi-squared test and univariate logistic regression analyses, as appropriate. RESULTS For 450,000 prescription orders 19,222 remote pharmacist interventions were documented. Frequency of interventions significantly increased each year (36% in 2009, 55% in 2010, and 7% in 2011) versus the baseline year (2008, 3%) when service started. The frequency of interventions also differed significantly across the eight hospitals and 16 remote pharmacists for the three defined intervention levels and categories. Remote pharmacist interventions at hospitals with an on-site and remote pharmacist (n=12,141) versus those with a remote pharmacist alone (n=7,081) were significantly more likely to be (1) patient-centered, (2) related to "actionable" medication management recommendations (unadjusted odds ratio [OR]=1.12), and (3) related to the "transcribing" (OR=1.47) and "prescribing" (OR=1.40) steps of the health system-centered medication use process level (all p<0.01). CONCLUSIONS This is one of the first studies to demonstrate the patient- and health system-centered nature of pharmaceutical care delivered via a telepharmacy service model by evaluating documented remote pharmacist interventions with an analytical framework.
Collapse
Affiliation(s)
- Jayashri Sankaranarayanan
- School of Pharmacy, Department of Pharmacy Practice, University of Connecticut, Hartford Hospital, Hartford, Connecticut
- College of Pharmacy, Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, Nebraska
| | - Lori J. Murante
- Alternate Site Pharmacies & Clinical Decision Support, The Nebraska Medical Center, Omaha, Nebraska
| | - Lisa M. Moffett
- Remote Pharmaceutical Care, Drug Information Service, The Nebraska Medical Center, Omaha, Nebraska
| |
Collapse
|
25
|
Khandoobhai A, Weber RJ. Issues facing pharmacy leaders in 2014: suggestions for pharmacy strategic planning. Hosp Pharm 2014; 49:295-302. [PMID: 24715750 PMCID: PMC3971116 DOI: 10.1310/hpj4903-295] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
In 2013, the Director's Forum published our assessment of issues facing pharmacy leaders to assist pharmacy directors in planning for the year ahead. The issues include health care reform and the Affordable Care Act, the American Society of Health-System Pharmacists Pharmacy Practice Model Initiative, the health care workforce, patients' perceptions of pharmacists, and the changing landscape of pharmacy education. Based on our environmental scan, the issues addressed in 2013 are pertinent to a department's plan for 2014. The goal of this article is to provide practical approaches to each of these issues to help pharmacy directors focus their department's goals for 2014 to support the development of patient-centered pharmacy services. This column will address (1) strategies to reduce medication costs and generate new pharmacy revenue streams, (2) innovative approaches to improving medication safety and quality, (3) steps to advance the clinical practice model, and (4) ways to create mutually beneficial student experiences.
Collapse
Affiliation(s)
- Anand Khandoobhai
- Specialty Practice Resident, MS Health-System Pharmacy Administration Resident , Columbus, Ohio
| | - Robert J Weber
- Administrator, Pharmacy Services, The Ohio State University Wexner Medical Center , Columbus, Ohio
| |
Collapse
|
26
|
Bubalo J, Warden BA, Wiegel JJ, Nishida T, Handel E, Svoboda LM, Nguyen L, Edillo PN. Does applying technology throughout the medication use process improve patient safety with antineoplastics? J Oncol Pharm Pract 2013; 20:445-60. [PMID: 24356802 DOI: 10.1177/1078155213514469] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PURPOSE Medical errors, in particular medication errors, continue to be a troublesome factor in the delivery of safe and effective patient care. Antineoplastic agents represent a group of medications highly susceptible to medication errors due to their complex regimens and narrow therapeutic indices. As the majority of these medication errors are frequently associated with breakdowns in poorly defined systems, developing technologies and evolving workflows seem to be a logical approach to provide added safeguards against medication errors. SUMMARY This article will review both the pros and cons of today's technologies and their ability to simplify the medication use process, reduce medication errors, improve documentation, improve healthcare costs and increase provider efficiency as relates to the use of antineoplastic therapy throughout the medication use process. Several technologies, mainly computerized provider order entry (CPOE), barcode medication administration (BCMA), smart pumps, electronic medication administration record (eMAR), and telepharmacy, have been well described and proven to reduce medication errors, improve adherence to quality metrics, and/or improve healthcare costs in a broad scope of patients. The utilization of these technologies during antineoplastic therapy is weak at best and lacking for most. Specific to the antineoplastic medication use system, the only technology with data to adequately support a claim of reduced medication errors is CPOE. In addition to the benefits these technologies can provide, it is also important to recognize their potential to induce new types of errors and inefficiencies which can negatively impact patient care. CONCLUSION The utilization of technology reduces but does not eliminate the potential for error. The evidence base to support technology in preventing medication errors is limited in general but even more deficient in the realm of antineoplastic therapy. Though CPOE has the best evidence to support its use in the antineoplastic population, benefit from many other technologies may have to be inferred based on data from other patient populations. As health systems begin to widely adopt and implement new technologies it is important to critically assess their effectiveness in improving patient safety.
Collapse
Affiliation(s)
- Joseph Bubalo
- Department of Pharmacy Services, Oregon Health & Science University, OR, USA
| | - Bruce A Warden
- Department of Pharmacy Services, Oregon Health & Science University, OR, USA
| | - Joshua J Wiegel
- Department of Pharmacy Services, Oregon Health & Science University, OR, USA
| | - Tess Nishida
- University of Washington Medical Center, WA, USA
| | - Evelyn Handel
- Department of Pharmacy Services, Roswell Park Cancer Institute, NY, USA
| | | | - Lam Nguyen
- Department of Pharmacy Services, Oregon Health & Science University, OR, USA
| | - P Neil Edillo
- Department of Pharmacy Services, Oregon Health & Science University, OR, USA
| |
Collapse
|
27
|
|
28
|
Cole SL, Grubbs JH, Din C, Nesbitt TS. Rural inpatient telepharmacy consultation demonstration for after-hours medication review. Telemed J E Health 2012; 18:530-7. [PMID: 22822940 DOI: 10.1089/tmj.2011.0222] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE Medication errors contribute to a significant number of fatal and nonfatal adverse medical events each year. Many actions, from both a policy and innovation standpoint, have been taken to reduce medication errors in the inpatient setting; yet, these actions often target larger urban hospitals. Rural hospitals face many more challenges in implementing these changes due to fewer resources and lower patient volumes. Our article discusses the implementation and results of a telepharmacy demonstration implemented between the University of California Davis Health System and six rural hospitals. MATERIALS AND METHODS A retrospective chart review obtained baseline medication errors for comparison with the prospective review of medication orders through telepharmacy. Medication orders from rural hospitals were transmitted via fax to the University of California Davis Pharmacy for after-hours review. If a medication required after-hours removal from the pharmacy, it was requested that video verification by a telepharmacist be used to verify that the correct medication was removed from the pharmacy. RESULTS Baseline findings from the retrospective chart review indicated that 30.0% of patients had one or more medication errors and that these errors occurred in 7.2% of the medication orders. None of these errors were found to have resulted in harm to the patients. During the telepharmacy demonstration, 2,378 medication orders were screened from 504 independent order review requests. In total, 58 (19.2%) patients had one or more medication errors. The errors from the telepharmacy demonstration represented potential errors that were identified through telepharmacy medication review. CONCLUSIONS Telepharmacy represents a potential alternative to around-the-clock on-site pharmacist medication review for rural hospitals.
Collapse
Affiliation(s)
- Stacey L Cole
- University of Utah School of Medicine, Salt Lake City, Utah 84132-2101, USA.
| | | | | | | |
Collapse
|
29
|
Krupinski EA, Patterson T, Norman CD, Roth Y, ElNasser Z, Abdeen Z, Noyek A, Sriharan A, Ignatieff A, Black S, Freedman M. Successful Models for Telehealth. Otolaryngol Clin North Am 2011; 44:1275-88, vii-viii. [DOI: 10.1016/j.otc.2011.08.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|